drugset / Trial / NCT03756883
Therapeutic Equivalence of Two Formulations of Fluticasone Propionate and Salmeterol Inhalation Powder in Subjects With Asthma
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A randomized, multiple-dose, blinded, placebo-controlled, parallel-group, multiple-center bioequivalence study with pharmacodynamic endpoints
Timeline
- Start
- 2018-12-03
- Primary completion
- 2019-10-26
- Completion
- 2019-11-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Fluticasone propionate | Other / unclassified | 100 ug | Inhaled |
| Comparator | Salmeterol | Other / unclassified | 50 ug | Inhaled |